Blue Trust Inc. Decreases Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Blue Trust Inc. reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 6.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,570 shares of the company’s stock after selling 1,700 shares during the period. Blue Trust Inc. owned 0.10% of OrthoPediatrics worth $678,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC grew its position in shares of OrthoPediatrics by 0.6% in the 2nd quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock valued at $2,098,000 after buying an additional 420 shares during the last quarter. Triodos Investment Management BV boosted its stake in OrthoPediatrics by 1.2% in the second quarter. Triodos Investment Management BV now owns 41,500 shares of the company’s stock valued at $1,194,000 after acquiring an additional 500 shares in the last quarter. Trust Point Inc. grew its holdings in shares of OrthoPediatrics by 10.0% during the third quarter. Trust Point Inc. now owns 8,532 shares of the company’s stock worth $231,000 after purchasing an additional 773 shares during the last quarter. EntryPoint Capital LLC increased its position in shares of OrthoPediatrics by 56.9% during the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after purchasing an additional 1,009 shares in the last quarter. Finally, Quest Partners LLC purchased a new stake in shares of OrthoPediatrics in the 2nd quarter valued at about $34,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Stock Down 3.0 %

OrthoPediatrics stock opened at $26.72 on Tuesday. The stock has a 50 day moving average of $28.46 and a two-hundred day moving average of $30.09. OrthoPediatrics Corp. has a twelve month low of $23.10 and a twelve month high of $36.23. The stock has a market capitalization of $636.71 million, a price-to-earnings ratio of -27.83 and a beta of 1.17. The company has a current ratio of 4.90, a quick ratio of 1.96 and a debt-to-equity ratio of 0.03.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Monday, August 5th. The company reported ($0.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.08. The firm had revenue of $52.80 million for the quarter, compared to analyst estimates of $52.40 million. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. As a group, research analysts expect that OrthoPediatrics Corp. will post -0.92 earnings per share for the current year.

Insider Buying and Selling

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of OrthoPediatrics stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total value of $293,000.00. Following the sale, the general counsel now owns 77,304 shares of the company’s stock, valued at approximately $2,265,007.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 31.80% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Truist Financial dropped their price target on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research note on Monday, October 14th. JMP Securities reissued a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.